Cookies and Privacy

To help offer the best experience possible, Guilford uses cookies on its site. By browsing here, you acknowledge our terms of use.
For more information, see our Cookie Policy. You can also read Guilford's Privacy Policy.

×
Skip to main content
Search
Search
Quick Search anywhere
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu

Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort)

Published Online:August 2022https://doi.org/10.1521/aeap.2022.34.4.272

Abstract

Overweight is increasingly prevalent in people living with HIV (PLWH), and is a high risk factor for metabolic disorders in this population. PLWH co-infected with hepatitis C virus (HCV) have a higher risk of metabolic disorders than their mono-infected counterparts. The putative relationship between cannabis use and body weight found in the general population has never been documented in HIV-HCV co-infected people. We tested whether cannabis use is associated with body mass index (BMI), overweight, and underweight in HCV co-infected PLWH (N = 992). Mixed-effects linear and logistic regression models were used to study the association between cannabis use and the three outcomes over time. After multivariable adjustment, cannabis use was inversely associated with BMI. Cannabis use was associated with a lower and higher risk of overweight and underweight, respectively. Cannabis use should be assessed and taken into account in the clinical management of the HIV-HCV co-infected population.

REFERENCES

  • Achhra A. C., , Sabin C., , Ryom L., , Hatleberg C., , Antonella d'Aminio M., , de Wit S., , Phillips A., , Pradier C., , Weber R., , Reiss P., , El-Sadr W., , Bonnet F., , Mocroft A., , Lundgren J., , Law M. G., & D:A:D Study Group . (2018). Body mass index and the risk of serious non-AIDS events and all-cause mortality in treated HIV-positive individuals: D: A: D cohort analysis. Journal of Acquired Immune Deficiency Syndromes (1999), 78(5), 579–588. https://doi.org/10.1097/QAI.0000000000001722 Crossref Medline, Google Scholar
  • Alam I., , Ullah N., , Alam I., , & Ali I. (2013). The effects and underlying mechanism of interferon therapy on body weight and body composition. Pakistan Journal of Pharmaceutical Sciences, 26(6), 1251–1257. Medline, Google Scholar
  • Alshaarawy O., , & Anthony J. C. (2019). Are cannabis users less likely to gain weight? Results from a national 3-year prospective study. International Journal of Epidemiology, 48(5), 1695–1700. https://doi.org/10.1093/ije/dyz044 Crossref Medline, Google Scholar
  • Audrain-McGovern J., , & Benowitz N. L. (2011). Cigarette smoking, nicotine, and body weight. Clinical Pharmacology and Therapeutics, 90(1), 164–168. https://doi.org/10.1038/clpt.2011.105 Crossref Medline, Google Scholar
  • Bailin S. S., , Gabriel C. L., , Wanjalla C. N., , & Koethe J. R. (2020). Obesity and weight gain in persons with HIV. Current HIV/AIDS Reports, 17(2), 138–150. https://doi.org/10.1007/s11904-020-00483-5 Crossref Medline, Google Scholar
  • Bares S. H., , Smeaton L. M., , Xu A., , Godfrey C., , & McComsey G. A. (2018). HIV-infected women gain more weight than HIV-infected men following the initiation of antiretroviral therapy. Journal of Women's Health, 27(9), 1162–1169. https://doi.org/10.1089/jwh.2017.6717 Crossref Medline, Google Scholar
  • Barré T., , Mercié P., , Marcellin F., , Esterle L., , Duvivier C., , Teicher E., , Bureau M., , Chas J., , Salmon-Céron D., , Sogni P., , Carrieri M. P., , Wittkop L., , Protopopescu C., & ANRS CO13 HEPAVIH Study Group . (2021). HCV cure and cannabis abstinence facilitate tobacco smoking quit attempts in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH Cohort Study). AIDS and Behavior, 25(12), 4141–4153. https://doi.org/10.1007/s10461-021-03277-x Crossref Medline, Google Scholar
  • Barré T., , Pol S., , Ramier C., , Di Beo V., , Carrat F., , Bureau M., , Bourlière M., , Dorival C., , Serfaty L., , Asselah T., , Boursier J., , Marcellin F., , Carrieri P., , Fontaine H., , Protopopescu C., & ANRS/AFEF Hepather Study Group . (2021). Cannabis use is inversely associated with overweight and obesity in hepatitis B virus-infected patients (ANRS CO22 Hepather Cohort). Cannabis and Cannabinoid Research. Advance online publication. https://doi.org/10.1089/can.2021.0094 Medline, Google Scholar
  • Bhattacharya D., , Umbleja T., , Carrat F., , Chung R. T., , Peters M. G., , Torriani F., , Anderson J., , & Currier J. S. (2010). Women experience higher rates of adverse events during HCV therapy in HIV infection: A meta-analysis. Journal of Acquired Immune Deficiency Syndromes (1999), 55(2), 170–175. https://doi.org/10.1097/QAI.0b013e3181e36420 Crossref Medline, Google Scholar
  • Bielawiec P., , Harasim-Symbor E., , & Chabowski A. (2020). Phytocannabinoids: Useful drugs for the treatment of obesity? Special focus on cannabidiol. Frontiers in Endocrinology, 11, 114. https://doi.org/10.3389/fendo.2020.00114 Crossref Medline, Google Scholar
  • Brunet L., , Moodie E. E. M., , Rollet K., , Cooper C., , Walmsley S., , Potter M., , Klein M. B., & Canadian Co-infection Cohort Investigators . (2013). Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: A longitudinal cohort analysis. Clinical Infectious Diseases, 57(5), 663–670. https://doi.org/10.1093/cid/cit378 Crossref Medline, Google Scholar
  • Buzón-Martín L. (2020). Weight gain in HIV-infected individuals using distinct antiretro-viral drugs. AIDS Reviews, 22(3), 158–167. https://doi.org/10.24875/AIDSRev.M20000036 Crossref Medline, Google Scholar
  • Carrieri M. P., , Protopopescu C., , Marcellin F., , Rosellini S., , Wittkop L., , Esterle L., , Zucman D., , Raffi F., , Rosenthal E., , Poizot-Martin I., , Salmon-Ceron D., , Dabis F., , & Spire B. (2017). Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. Journal of Hepatology, 67(6), 1157–1167. https://doi.org/10.1016/j.jhep.2017.08.005 Crossref Medline, Google Scholar
  • Carrieri M. P., , Protopopescu C., , Marcellin F., , Wittkop L., , Lacombe K., , Esterle L., , Sogni P., , Salmon-Ceron D., & ANRS CO13 HEPAVIH Study Group . (2018). The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients. Journal of Hepatology, 68(4), 845–847. https://doi.org/10.1016/j.jhep.2017.10.025 Crossref Medline, Google Scholar
  • Chalouni M., , Pol S., , Sogni P., , Fontaine H., , Lacombe K., , Marc-Lacombe J., , Esterle L., , Dorival C., , Bourlière M., , Bani-Sadr F., , de Ledinghen V., , Zucman D., , Larrey D., , Salmon D., , Carrat F., , Wittkop L., & ANRS CO13 HEPAVIH and ANRS CO22 HEPATHER cohort study groups . (2021). Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death. Journal of Hepatology, 74(1), 37–47. https://doi.org/10.1016/j.jhep.2020.08.008 Crossref Medline, Google Scholar
  • Clark T. M., , Jones J. M., , Hall A. G., , Tabner S. A., , & Kmiec R. L. (2018). Theoretical explanation for reduced body mass index and obesity rates in cannabis users. Cannabis and Cannabinoid Research, 3(1), 259–271. https://doi.org/10.1089/can.2018.0045 Crossref Medline, Google Scholar
  • Cluny N. L., , Keenan C. M., , Reimer R. A., , Le Foll B., , & Sharkey K. A. (2015). Prevention of diet-induced obesity effects on body weight and gut microbiota in mice treated chronically with Δ9-tetrahydrocannabinol. PLoS One, 10(12), e0144270. https://doi.org/10.1371/journal.pone.0144270 Crossref Medline, Google Scholar
  • Costiniuk C. T., , Saneei Z., , Salahuddin S., , Cox J., , Routy J.-P., , Rueda S., , Abdallah S. J., , Jensen D., , Lebouché B., , Brouillette M. J., , Klein M., , Szabo J., , Frenette C., , Giannakis A., , & Jenabian M.-A. (2019). Cannabis consumption in people living with HIV: Reasons for use, secondary effects, and opportunities for health education. Cannabis and Cannabinoid Research, 4(3), 204–213. https://doi.org/10.1089/can.2018.0068 Crossref Medline, Google Scholar
  • Crum-Cianflone N., , Roediger M. P., , Eberly L., , Headd M., , Marconi V., , Ganesan A., , Weintrob A., , Barthel R. V., , Fraser S., , Agan B. K., & Infectious Disease Clinical Research Program HIV Working Group . (2010). Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One, 5(4), e10106. https://doi.org/10.1371/journal.pone.0010106 Crossref Medline, Google Scholar
  • Davis K., , Perez-Guzman P., , Hoyer A., , Brinks R., , Gregg E., , Althoff K. N., , Justice A. C., , Reiss P., , Gregson S., , & Smit M. (2021). Association between HIV infection and hypertension: A global systematic review and meta-analysis of cross-sectional studies. BMC Medicine, 19, 105. https://doi.org/10.1186/s12916-021-01978-7 Crossref Medline, Google Scholar
  • Di Marzo V., , & Després J.-P. (2009). CB1 antagonists for obesity—What lessons have we learned from rimonabant? Nature Reviews Endocrinology, 5(11), 633–638. https://doi.org/10.1038/nrendo.2009.197 Crossref Medline, Google Scholar
  • Di Marzo V., , & Silvestri C. (2019). Lifestyle and metabolic syndrome: Contribution of the endocannabinoidome. Nutrients, 11(8), 1956. https://doi.org/10.3390/nu11081956 Crossref, Google Scholar
  • Erlandson K. M., , Zhang L., , Lake J. E., , Schrack J., , Althoff K., , Sharma A., , Tien P. C., , Margolick J. B., , Jacobson L. P., , & Brown T. T. (2016). Changes in weight and weight distribution across the lifespan among HIV-infected and-uninfected men and women. Medicine, 95(46), e5399. https://doi.org/10.1097/MD.0000000000005399 Crossref Medline, Google Scholar
  • Fahme S., , Bloomfield G. S., , & Peck R. (2018). Hypertension in HIV-infected adults: Novel pathophysiologic mechanisms. Hypertension (Dallas, Tex.: 1979), 72(1), 44–55. https://doi.org/10.1161/HYPERTENSIONAHA.118.10893 Crossref Medline, Google Scholar
  • Foltin R. W., , Fischman M. W., , & Byrne M. F. (1988). Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite, 11(1), 1–14. https://doi.org/10.1016/s0195-6663(88)80017-5 Crossref Medline, Google Scholar
  • Fuhrer R., , & Rouillon F. (1989). La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'autoévaluation [The French version of the CES-D (Center for Epidemiologic Studies-Depression Scale). Description and translation of the self-assessment scale]. Psychiatrie & Psychobiologie, 4(3), 163–166. Google Scholar
  • Funke B., , Spinner C. D., , Esser S., , Stellbrink H. J., , Stoehr A., , Wolf E., , Koegl C., , Bruening J., , & Witte V. (2021). High prevalence of recreational and illicit drug use in German people living with HIV with a potential for drug-drug interactions with antiretroviral therapy. International Journal of STD & AIDS, 32(1), 75–82. https://doi.org/10.1177/0956462420959169 Crossref Medline, Google Scholar
  • Goupil de Bouillé J., , Vigouroux C., , Plessis L., , Ghislain M., , Teglas J.-P., , Boufassa F., , Goujard C., , Vignes D., , Bouchaud O., , Salmon D., , Meyer L., , & Abgrall S. (2021). Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy: Socio-clinical, inflammation, and metabolic markers. Journal of Infectious Diseases, 224(9), 1570–1580. https://doi.org/10.1093/infdis/jiab151 Crossref Medline, Google Scholar
  • Hanttu A., , Kauppinen K. J., , Kivelä P., , Ollgren J., , Jousilahti P., , Liitsola K., , Koponen P., , & Sutinen J. (2021). Prevalence of obesity and disturbances in glucose homeostasis in HIV-infected subjects and general population— Missed diagnoses of diabetes? HIV Medicine, 22(4), 244–253. https://doi.org/10.1111/hiv.13009 Crossref Medline, Google Scholar
  • Hindocha C., , Freeman T. P., , Ferris J. A., , Lynskey M. T., , & Winstock A. R. (2016). No smoke without tobacco: A global overview of cannabis and tobacco routes of administration and their association with intention to quit. Frontiers in Psychiatry, 7, 104. https://doi.org/10.3389/fpsyt.2016.00104 Crossref Medline, Google Scholar
  • Huis In 't Veld D., , Pengpid S., , Colebunders R., , & Peltzer K. (2018). Body mass index and waist circumference in patients with HIV in South Africa and associated socio-demographic, health related and psychosocial factors. AIDS and Behavior, 22(6), 1972–1986. https://doi.org/10.1007/s10461-017-1737-2 Crossref Medline, Google Scholar
  • Iversen J., , Page K., , Madden A., , & Maher L. (2015). HIV, HCV and health-related harms among women who inject drugs: Implications for prevention and treatment. Journal of Acquired Immune Deficiency Syndromes (1999), 69(1), S176–S181. https://doi.org/10.1097/QAI.0000000000000659 Crossref Medline, Google Scholar
  • Jiang J., , Qin X., , Liu H., , Meng S., , Abdullah A. S., , Huang J., , Qin C., , Liu Y., , Huang Y., , Qin F., , Huang J., , Zang N., , Liang B., , Ning C., , Liao Y., , Liang H., , Wu F., , & Ye L. (2019). An optimal BMI range associated with a lower risk of mortality among HIV-infected adults initiating antiretroviral therapy in Guangxi, China. Scientific Reports, 9(1), 7816. https://doi.org/10.1038/s41598-019-44279-z Crossref Medline, Google Scholar
  • Jung I. Y., , Rupasinghe D., , Woolley I., , O'Connor C. C., , Giles M., , Azwa R. I., , & Choi J. Y. (2019). Trends in mortality among ART-treated HIV-infected adults in the Asia-Pacific region between 1999 and 2017: Results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia-Pacific. Journal of the International AIDS Society, 22(1), e25219. https://doi.org/10.1002/jia2.25219 Crossref Medline, Google Scholar
  • Koethe J. R., , Jenkins C. A., , Lau B., , Shepherd B. E., , Justice A. C., , Tate J. P., , Buchacz K., , Napravnik S., , Mayor A. M., , Horberg M. A., , Blashill A. J., , Willig A., , Wester C. W., , Silverberg M. J., , Gill J., , Thorne J. E., , Klein M., , Eron J. J., , Kitahata M. M., … North American AIDS Cohort Collaboration on Research and Design (NAACCORD) . (2016). Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Research and Human Retroviruses, 32(1), 50–58. https://doi.org/10.1089/aid.2015.0147 Crossref Medline, Google Scholar
  • Kumar S., , & Samaras K. (2018). The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality. Frontiers in Endocrinology, 9, 705. https://doi.org/10.3389/fendo.2018.00705 Crossref Medline, Google Scholar
  • Lee J. T., , Saag L. A., , Kipp A. M., , Logan J., , Shepherd B. E., , Koethe J. R., , Turner M., , Bebawy S., , Sterling T. R., , & Hulgan T. (2020). Self-reported cannabis use and changes in body mass index, CD4 T-cell counts, and HIV-1 RNA suppression in treated persons with HIV. AIDS and Behavior, 24(4), 1275–1280. https://doi.org/10.1007/s10461-019-02430-x Crossref Medline, Google Scholar
  • Loko M.-A., , Salmon D., , Carrieri P., , Winnock M., , Mora M., , Merchadou L., , Gillet S., , Pambrun E., , Delaune J., , Valantin M. A., , Poizot-Martin I., , Neau D., , Bonnard P., , Rosenthal E., , Barange K., , Morlat P., , Lacombe K., , Gervais A., , Rouges F., … ANRS CO 13 HEPAVIH Study Group . (2010). The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006–2010. BMC Infectious Diseases, 10, 303. https://doi.org/10.1186/1471-2334-10-303 Crossref Medline, Google Scholar
  • Maggi P., , Di Biagio A., , Rusconi S., , Cicalini S., , D'Abbraccio M., , d'Ettorre G., , Martinelli C., , Nunnari G., , Sighinolfi L., , Spagnuolo V., , & Squillace N. (2017). Cardiovascular risk and dyslipidemia among persons living with HIV: A review. BMC Infectious Diseases, 17, 551. https://doi.org/10.1186/s12879-017-2626-z Crossref Medline, Google Scholar
  • McCombie L., , Elliott L., , Farrow K., , Gruer L., , Morrison A., , & Cameron J. (1995). Injecting drug use and body mass index. Addiction (Abingdon, England), 90(8), 1117–1118. https://doi.org/10.1046/j.1360-0443.1995.908111711.x Crossref Medline, Google Scholar
  • Meier M. H., , Pardini D., , Beardslee J., , & Matthews K. A. (2019). Associations between cannabis use and cardiometabolic risk factors: A longitudinal study of men. Psychosomatic Medicine, 81(3), 281–288. https://doi.org/10.1097/PSY.0000000000000665 Crossref Medline, Google Scholar
  • Ngueta G., , Bélanger R. E., , Laouan-Sidi E. A., , & Lucas M. (2015). Cannabis use in relation to obesity and insulin resistance in the Inuit population. Obesity (Silver Spring, Md.), 23(2), 290–295. https://doi.org/10.1002/oby.20973 Crossref Medline, Google Scholar
  • Nordmann S., , Vilotitch A., , Roux P., , Esterle L., , Spire B., , Marcellin F., , Salmon-Ceron D., , Dabis F., , Chas J., , Rey D., , Wittkop L., , Sogni P., , Carrieri P., , & Rosellini S. (2017). Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH). Journal of Viral Hepatitis, 25(2), 171–179. https://doi.org/10.1111/jvh.12797 Crossref Medline, Google Scholar
  • Noubissi E. C., , Katte J.-C., , & Sobngwi E. (2018). Diabetes and HIV. Current Diabetes Reports, 18(11), 125. https://doi.org/10.1007/s11892-018-1076-3 Crossref Medline, Google Scholar
  • Osibogun O., , Ogunmoroti O., , Michos E. D., , Spatz E. S., , Olubajo B., , Nasir K., , Madhivanan P., , & Maziak W. (2017). HIV/HCV coinfection and the risk of cardiovascular disease: A meta-analysis. Journal of Viral Hepatitis, 24(11), 998–1004. https://doi.org/10.1111/jvh.12725 Crossref Medline, Google Scholar
  • Pacek L. R., , Towe S. L., , Hobkirk A. L., , Nash D., , & Goodwin R. D. (2018). Frequency of cannabis use and medical cannabis use among persons living with HIV in the United States: Findings from a nationally representative sample. AIDS Education and Prevention, 30(2), 169–181. https://doi.org/10.1521/aeap.2018.30.2.169 Link, Google Scholar
  • Pasman J. A., , Verweij K. J. H., , Gerring Z., , Stringer S., , Sanchez-Roige S., , Treur J. L., , Abdellaoui A., , Nivard M. G., , Baselmans B., , Ong J. S., , Ip H. F., , van der Zee M. D., , Bartels M., , Day F. R., , Fontanillas P., , Elson S. L., , 23andMe Research Team, de Wit, H, ., Davis L. K., , … Vink J. M. (2018). GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Nature Neuroscience, 21(9), 11611170. https://doi.org/10.1038/s41593-018-0206-1 Crossref, Google Scholar
  • Pourcher G., , Costagliola D., , & Martinez V. (2015). Obesity in HIV-infected patients in France: Prevalence and surgical treatment options. Journal of Visceral Surgery, 152(1), 33–37. https://doi.org/10.1016/j.jviscsurg.2014.12.001 Crossref Medline, Google Scholar
  • Protopopescu C., , Santos M. E., , Sogni P., , Marcellin F., , Esterle L., , Wittkop L., , … Carrieri M. P. (2018). Protective effect of cannabis and coffee consumption on HCV-related mortality in French HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort). Journal of Hepatology, 68, S142–S143. https://doi.org/10.1016/S0168-8278(18)30501-4 Crossref, Google Scholar
  • Radloff L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306 Crossref, Google Scholar
  • Russell E., , Albert A., , Côté H., , Hsieh A., , Nesbitt A., , Campbell A. R., , Maan E. J., , Brophy J., , Pick N., , & Murray M. (2020). Rate of dyslipidemia higher among women living with HIV: A comparison of metabolic and cardiovascular health in a cohort to study aging in HIV. HIV Medicine, 21(7), 418–428. https://doi.org/10.1111/hiv.12843 Crossref Medline, Google Scholar
  • Santos M. E., , Protopopescu C., , Sogni P., , Yaya I., , Piroth L., , Bailly F., , Marcellin F., , Esterle L., , Wittkop L., , Rosenthal E., , Morlat P., , Roux P., , de Araujo W. N., , Salmon-Ceron D., , Carrieri M. P., & ANRS CO13 HEPAVIH Study Group . (2020). HCV-related mortality among HIV/HCV co-infected patients: The importance of behaviors in the HCV cure era (ANRS CO13 HEPAVIH Cohort). AIDS and Behavior, 24(4), 1069–1084. https://doi.org/10.1007/s10461-019-02585-7 Crossref Medline, Google Scholar
  • Sax P. E., , Erlandson K. M., , Lake J. E., , Mccomsey G. A., , Orkin C., , Esser S., , Brown T. T., , Rockstroh J. K., , Wei X., , Carter C. C., , Zhong L., , Brainard D. M., , Melbourne K., , Das M., , Stellbrink H. J., , Post F. A., , Waters L., , & Koethe J. R. (2020). Weight gain following initiation of antiretroviral therapy: Risk factors in randomized comparative clinical trials. Clinical Infectious Diseases, 71(6), 1379–1389. https://doi.org/10.1093/cid/ciz999 Crossref Medline, Google Scholar
  • Schouten J., , Wit F. W., , Stolte I. G., , Kootstra N. A., , van der Valk M., , Geerlings S. E., , Prins M., , Reiss P., & AGEhIV Cohort Study Group . (2014). Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: The AGEhIV cohort study. Clinical Infectious Diseases, 59(12), 1787–1797. https://doi.org/10.1093/cid/ciu701 Crossref Medline, Google Scholar
  • Shah S., , Hindley L., , & Hill A. (2021). Are new antiretroviral treatments increasing the risk of weight gain? Drugs, 81(3), 299–315. https://doi.org/10.1007/s40265-020-01457-y Crossref Medline, Google Scholar
  • Sharma A., , Hoover D. R., , Shi Q., , Gustafson D., , Plankey M. W., , Hershow R. C., , Tien P. C., , Golub E. T., , & Anastos K. (2015). Relationship between body mass index and mortality in HIV-infected HAART users in the Women's Interagency HIV Study. PLoS One, 10(12), e0143740. https://doi.org/10.1371/journal.pone.0143740 Crossref Medline, Google Scholar
  • Sidney S. (2016). Marijuana use and Type 2 diabetes mellitus: A review. Current Diabetes Reports, 16(11), 117. https://doi.org/10.1007/s11892-016-0795-6 Crossref Medline, Google Scholar
  • Tang A. M., , Forrester J. E., , Spiegelman D., , Flanigan T., , Dobs A., , Skinner S., , & Wanke C. (2010). Heavy injection drug use is associated with lower percent body fat in a multi-ethnic cohort of HIV-positive and HIV-negative drug users from three U.S. cities. American Journal of Drug and Alcohol Abuse, 36(1), 78–86. https://doi.org/10.3109/00952990903544851 Crossref Medline, Google Scholar
  • Towe S. L., , Horton O. E., , Martin B., , & Meade C. S. (2018). A comparison of motivations for marijuana use in HIV-positive and HIV-negative adults. AIDS and Behavior, 22(9), 2807–2814. https://doi.org/10.1007/s10461-018-2123-4 Crossref Medline, Google Scholar
  • Traversy G., , & Chaput J.-P. (2015). Alcohol consumption and obesity: An update. Current Obesity Reports, 4(1), 122–130. https://doi.org/10.1007/s13679-014-0129-4 Crossref Medline, Google Scholar
  • van Welzen B. J., , Mudrikova T., , El Idrissi A., , Hoepelman A. I. M., , & Arends J. E. (2019). A review of non-alcoholic fatty liver disease in HIV-infected patients: The next big thing? Infectious Diseases and Therapy, 8(1), 33–50. https://doi.org/10.1007/s40121-018-0229-7 Crossref Medline, Google Scholar
  • World Health Organization . (2019). Body mass index—BMI. Retrieved July 9, 2019, from http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-life-style/body-mass-index-bmi Google Scholar
  • Yuh B., , Tate J., , Butt A. A., , Crothers K., , Freiberg M., , Leaf D., , Logeais M., , Rimland D., , Rodriguez-Barradas M. C., , Ruser C., , & Justice A. C. (2015). Weight change after antiretroviral therapy and mortality. Clinical Infectious Diseases, 60(12), 1852–1859. https://doi.org/10.1093/cid/civ192 Crossref Medline, Google Scholar
Previous article
Next article